deoxyepinephrine has been researched along with Arrhythmias, Cardiac in 10 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibopamine is a dopaminergic and adrenergic receptor agonist, which is active in the treatment of congestive heart failure." | 9.06 | Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. ( , 1989) |
| "The substitution of digoxin with ibopamine, a new inotropic and vasodilating agent, was evaluated in a multicenter study in 58 patients with mild-to-moderate congestive heart failure, stabilized on diuretics, and digoxin therapy." | 9.06 | Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group. ( Abbondati, G; Cavalli, A; Fuccella, LM; Riva, E; Schleman, M, 1989) |
| "Seven male patients suffering from angina pectoris with spontaneous premature ventricular beats were given oral ibopamine 50 mg t." | 7.66 | Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. ( Maggi, GC; Montani, E; Triulzi, MO, 1982) |
| " The results rather suggest that long-term treatment with ibopamine affords an increase in survival and a delay in the progression of the disease, without adverse effects on cardiac rhythm and myocardial oxygen balance, and with a general improvement in the patients' quality of life." | 6.67 | Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results. ( Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F, 1991) |
| "Ibopamine is a dopaminergic and adrenergic receptor agonist, which is active in the treatment of congestive heart failure." | 5.06 | Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. ( , 1989) |
| "The substitution of digoxin with ibopamine, a new inotropic and vasodilating agent, was evaluated in a multicenter study in 58 patients with mild-to-moderate congestive heart failure, stabilized on diuretics, and digoxin therapy." | 5.06 | Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group. ( Abbondati, G; Cavalli, A; Fuccella, LM; Riva, E; Schleman, M, 1989) |
| "This study compares the effects of digoxin, placebo and ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyl-dopamine, on exercise tolerance and cardiac rhythm of 14 patients whose left ventricular heart failure (end-diastolic pressure, 26." | 5.06 | Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure. ( Brusoni, B; Cadel, A; Carati, L; Fanciulli, R; Osculati, G; Pirelli, P; Rovati, A; Valagussa, F, 1986) |
| "Seven male patients suffering from angina pectoris with spontaneous premature ventricular beats were given oral ibopamine 50 mg t." | 3.66 | Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. ( Maggi, GC; Montani, E; Triulzi, MO, 1982) |
| " The results rather suggest that long-term treatment with ibopamine affords an increase in survival and a delay in the progression of the disease, without adverse effects on cardiac rhythm and myocardial oxygen balance, and with a general improvement in the patients' quality of life." | 2.67 | Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results. ( Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F, 1991) |
| "Ibopamine was not found to facilitate the occurrence of atrial and/or ventricular arrhythmias." | 1.27 | The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies. ( Breccia Fratadocchi, G; Capestro, F; Ciampani, N; Massacci, C; Mocchegiani, R; Purcaro, A; Ruga, O, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montani, E | 1 |
| Triulzi, MO | 1 |
| Maggi, GC | 1 |
| Sher, D | 2 |
| Licciardello, L | 3 |
| Ferrari, V | 2 |
| Sirtori, F | 1 |
| Cesana, B | 1 |
| Caponnetto, S | 2 |
| Terrachini, V | 2 |
| Canale, C | 2 |
| Bruzzone, F | 2 |
| Masperone, MA | 1 |
| Pastorino, L | 1 |
| Marchetti, GV | 2 |
| Cavalli, A | 1 |
| Riva, E | 1 |
| Schleman, M | 1 |
| Abbondati, G | 1 |
| Fuccella, LM | 1 |
| Goldberg, LI | 1 |
| Rajfer, SI | 1 |
| Ciampani, N | 1 |
| Massacci, C | 1 |
| Capestro, F | 1 |
| Breccia Fratadocchi, G | 1 |
| Mocchegiani, R | 1 |
| Ruga, O | 1 |
| Purcaro, A | 1 |
| Cadel, A | 1 |
| Brusoni, B | 1 |
| Pirelli, P | 1 |
| Osculati, G | 1 |
| Rovati, A | 1 |
| Fanciulli, R | 1 |
| Carati, L | 1 |
| Valagussa, F | 1 |
6 trials available for deoxyepinephrine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; C | 1991 |
Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiotonic Agen | 1989 |
Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Dopamine | 1989 |
Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group.
Topics: Adult; Aged; Arrhythmias, Cardiac; Deoxyepinephrine; Digoxin; Dopamine; Echocardiography; Exercise T | 1989 |
Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular Diseases; Deoxyepine | 1987 |
Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Dopamine; Female; Heart F | 1986 |
4 other studies available for deoxyepinephrine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Deoxyepinephrine; Dopamine; Electrocardiography; Heart | 1982 |
Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
Topics: Administration, Oral; Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Cardiotonic Agents; D | 1990 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopa | 1985 |
The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Electrocardiograp | 1986 |